SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bengalus who wrote (88)1/29/1999 9:35:00 PM
From: Mad2  Read Replies (3) of 5582
 
Bengalus,
Here's ABI's listing on Gel-Tech.
Given that GUMM really doesn't bring anything to the table leads me to the conclusion that the reason for the "venture " is to pump GUMM's stock. Anyone seriously looking into GUMM should first look at QGLY as they have been selling homopathic cold remidies in table form (cold-ease) and have a market cap of 68 mil. this cold thingy with GUMM is a bunch of hype.

Copyright 1998 American Business Information
ABI US Business Directory

GEL-TECH INDUSTRIES
6430 VARIEL AVE # 102B
WOODLAND HILLS, CA 91367-2520 UNITED STATES
TEL: 818-340-3497 FAX: 818-340-3427
ABI-NO: 985604685

COUNTY: 06037 LOS ANGELES

POPULATION: 1 - 24,999 AA

CARRIER-CODE: C019

PRI-SIC: 512203 PHARMACEUTICAL PRODUCTS-WHOLESALE

LOC-SALES: 5,000,000 - 9,999,999 EE

LOC-EMPLOYEES: 10

PAR-EMPLOYEES: UNKNOWN

BUSINESS-ORG: FIRM

EXECUTIVES: R STEVEN DAVIDISON, OWNER

AD-SIZE: REGULAR LISTING

CREDIT: UNKNOWN

LANGUAGE: ENGLISH

LOAD-DATE: December 31, 1998
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext